Press Release - Hepatitis E, tetanus and hepatitis B all pose significant but under-reported threats to the health and lives ...

Molecular diagnosis of HAV along with anti-HAV IgG avidity measurement are helpful in case of positive IgM where laboratory evidence of acute hepatitis is absent and there is no epidemiologic link ...

Gilead Sciences, Inc. today announced the presentation of late-breaking data and multiple oral presentations from its innovative HIV treatment portfolio and pipeline at the Conference on Retroviruses ...

Studies show that the PCR detection of HAV RNA has an important role in the early diagnosis of infection, especially in the window period during outbreaks and in cases of acute hepatitis with ...

From the column: "Health care providers are battling the storm, on a seemingly impossible quest to repair the tattered mess ...

Bank of New York Mellon Corp grew its stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 10.8% in the fourth quarter, Holdings Channel reports. The institutional investor owned ...

Several studies have suggested that COVID-19 may increase a person’s risk of developing cancer or promote metastasis of existing cancer.

Sex differences in the risk factors, diagnosis, treatment, and outcomes of patients with cardiovascular disease have been ...

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...

Karin Martin couldn't sleep last Sunday night after reading a letter from Toronto Public Health that drowned her with worry.